authorization

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated…

2 days ago

Glidian Joins Infinx to Advance Prior Authorization Automation and Expand Market Reach

MUMBAI, India and CUPERTINO, Calif., March 25, 2025 /PRNewswire/ -- Infinx, a leader in AI-powered revenue cycle management solutions, announces…

2 weeks ago

Databricks Achieves FedRAMP High Authorization for AWS GovCloud

Hires industry veteran Mike Daniels to lead public sector practice amid rapidly growing demand for data intelligence  SAN FRANCISCO, Feb.…

1 month ago

MET DEVELOPMENT (MAIRE), ENI AND IREN START THE AUTHORIZATION PROCESS FOR A CIRCULAR METHANOL AND HYDROGEN PLANT IN ITALY BASED ON NEXTCHEM’S NX CIRCULARTM TECHNOLOGY

NEXTCHEM's NX CircularTM waste-to-energy gasification technology allows Eni's Sannazzaro de' Burgondi refinery to produce synthesis gas converted to low-carbon circular…

2 months ago

Valneva Receives Marketing Authorization in the UK for the Worlds First Chikungunya Vaccine, IXCHIQ

Saint Herblain (France), February 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

2 months ago

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

2 months ago

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

3 months ago

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

3 months ago

Databricks Achieves Authorization for DoD IL5 on AWS GovCloud

Databricks is now generally available on AWS GovCloud SAN FRANCISCO, Nov. 18, 2024 /PRNewswire/ -- Databricks, the Data and AI company,…

5 months ago

Databricks Achieves Authorization for DoD IL5 on AWS GovCloud

Databricks is now generally available on AWS GovCloud SAN FRANCISCO, Nov. 18, 2024 /PRNewswire/ -- Databricks, the Data and AI company,…

5 months ago